|
HS Code |
671250 |
| Chemical Name | Flumethasone Acid |
| Cas Number | 2135-17-3 |
| Molecular Formula | C22H28F2O5 |
| Molecular Weight | 410.45 g/mol |
| Appearance | White to off-white powder |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Melting Point | About 260-261°C |
| Storage Temperature | 2-8°C |
| Purity | Typically ≥98% |
| Synonyms | 6α,9α-Difluoro-11β,17α,21-trihydroxy-4-pregnen-3,20-dione-17-propionic acid |
| Usage | Pharmaceutical intermediate |
As an accredited Flumethasone Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Flumethasone Acid is supplied in a 25g amber glass vial with a tamper-evident cap, labeled with safety and product details. |
| Shipping | Flumethasone Acid is shipped in tightly sealed, appropriately labeled containers compliant with regulatory standards. It should be protected from light, moisture, and extreme temperatures during transit. Shipping is handled by authorized carriers with proper documentation and safety data sheets, ensuring safe and secure delivery according to chemical safety guidelines. |
| Storage | Flumethasone Acid should be stored in a tightly sealed container, protected from light and moisture. Keep it at room temperature, ideally between 15°C and 25°C (59°F to 77°F). Store in a cool, dry, and well-ventilated area away from incompatible substances, such as strong oxidizing agents. Ensure that it is kept out of reach of children and unauthorized personnel. |
|
Purity 99%: Flumethasone Acid with purity 99% is used in the formulation of ophthalmic solutions, where it ensures high anti-inflammatory efficacy. Molecular Weight 434.5 g/mol: Flumethasone Acid with molecular weight 434.5 g/mol is used in topical corticosteroid creams, where it enables precise dosing and consistent drug delivery. Melting Point 237°C: Flumethasone Acid with melting point 237°C is used in sterile powder injections, where it guarantees thermal stability during sterilization. Particle Size D90 <10 µm: Flumethasone Acid with particle size D90 <10 µm is used in inhalable corticosteroid preparations, where it promotes rapid pulmonary absorption. Stability Temperature up to 40°C: Flumethasone Acid stable up to 40°C is used in tropical region pharmaceuticals, where it maintains potency in challenging storage conditions. Solubility 2 mg/mL in ethanol: Flumethasone Acid with solubility 2 mg/mL in ethanol is used in semi-solid gels, where it provides uniform dispersion and enhanced topical bioavailability. Assay ≥98.5%: Flumethasone Acid with assay ≥98.5% is used in dermatological ointments, where it achieves reliable anti-allergic performance. |
Competitive Flumethasone Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Corticosteroids have shaped the treatment landscape for inflammatory diseases, allergies, and autoimmune disorders, but not every steroid works the same. Flumethasone acid steps up as a unique solution for several reasons. Unlike other glucocorticoids, flumethasone acid blends potent anti-inflammatory strength with a more manageable side effect profile, and I’ve seen firsthand how users often benefit from these distinctions.
Out in the field, veterinarians and medical practitioners sometimes find flumethasone acid to be the “go-to” when standard corticosteroids fall short or introduce complications. The active molecule packs a punch at low doses, making it a strong candidate for cases where other steroids lose ground to resistance or intolerance. What sets this compound apart is not just power—it's about precision; it delivers targeted inflammation management, so less drug delivers more effect.
This product usually arrives in its pure acid form, with chemical purity above 98%. Most manufacturers supply it as a fine, white to light ivory crystalline powder. That clarity and consistency directly affect mixing and stability, which anybody working in clinical or industrial labs can appreciate. Good flumethasone acid dissolves quickly in dimethyl sulfoxide, and its chemical configuration keeps it reasonably stable during storage, which goes a long way toward reducing waste and batch failure.
Exact model tags might depend on the supplier, but the important factors revolve around analytical assurance—high-resolution HPLC fingerprints and tight impurity controls safeguard users from unwelcome surprises. The molecule itself carries the formula C22H28F2O5. Its molecular weight of 410.45 Daltons influences dosing and preparation, but in day-to-day work, users value that it remains free-flowing, simple to weigh, and reliably potent. In both research and practice, this removes frustrating guesswork from compounding.
Flumethasone acid has earned a seat in both research settings and clinical practice, most obviously within the veterinary sphere but also in various advanced pharmaceutical preparations. While some corticosteroids see broad use, flumethasone acid arrives where control is crucial, such as in managing stubborn skin conditions or severe inflammatory responses that don’t quiet down easily. It has become the backbone of formulations where over-activity of the immune system leads to tissue damage.
I’ve seen practitioners reach for this product in cases involving equines, canines, or livestock, especially when rapid results matter. For example, allergic dermatitis in dogs or horses often fails to resolve through weaker steroids, making the precise action of flumethasone acid indispensable. Dermatologists and immunologists, too, turn to the compound for stubborn cases, harnessing its predictable absorption and effectiveness. In certain countries, flumethasone acid also plays a role as an intermediate in synthesizing combination products for topical, injectable, or oral medications.
Not all corticosteroids match the balance of safety and punch found in flumethasone acid. Some, like prednisolone, trend toward a blunt approach—more side effects, less selective targeting, and greater risk during long-term use. Dexamethasone, another strong contender, can still cause trouble with water retention or tissue breakdown when overused. Compared to these, flumethasone acid carries a lower risk of sodium retention, reducing chances of high blood pressure, edema, or undesirable shifts in potassium. This matters in both daily patient care and long-haul treatments.
Feedback from users often centers on the smoother tapering process. Stopping corticosteroid use always poses a risk, but the precise dosing flumethasone acid enables lets clinicians transition patients more gently—cutting down withdrawal symptoms and hormone imbalances.
Pharmacologically, the molecule’s affinity for the glucocorticoid receptor and minimal mineralocorticoid activity means less off-target activity in the kidneys. Animals (and people) suffer fewer disruptions to fluid balance or blood pressure. This quality lets animal caregivers push clinical boundaries a little without worrying too much about steroid-induced complications.
Working through supply chains and laboratories, I’ve come across plenty of differences in how corticosteroids are handled and stored. Flumethasone acid, by remaining stable under standard conditions away from direct sunlight and excess moisture, removes some of those headaches. Shipping high-value molecules makes people nervous, but suppliers favoring robust batch testing protocols give clinicians predictable quality. Labs appreciate the reproducible spectrum during testing—peaks match up, and there’s little sign of impurities.
Practitioners should always track shelf life and label claims on purity. Some providers cut corners, but trustworthy documentation and lot traceability shield users from counterfeit or degraded products. In recent years, regulatory bodies have encouraged more scrutiny over both raw corticosteroid and finished dosage forms; flumethasone acid holds its ground thanks to transparency from reputable sources.
Research literature points toward flumethasone acid’s superior anti-inflammatory action compared to several other agents—often two to five times stronger than hydrocortisone on a weight-for-weight basis. Clinical studies in both farm animals and companion species show more rapid control of swelling and immune overreactions, especially in allergic or hypersensitive subjects.
I’ve listened to veterinarians echo these findings in case reports and peer groups: Recovery rates tick upward, and adverse reactions remain uncommon. In dermatological trials, topical flumethasone compounds provide quicker symptom relief for severe eczema or pruritic lesions than older steroidal creams, resulting in happier patients and fewer callbacks. These outcomes add real value for clinics and animal owners alike.
No powerful agent comes totally free of risk or oversight. One ongoing issue with corticosteroids revolves around potential misuse by non-experts, dosing errors, or attempts to bypass veterinary oversight to cut corners. In the hands of trained users, flumethasone acid adds flexibility and reliable action, but education stays front and center—misapplication can still trigger negative side effects, metabolic disturbances, or immune suppression. Overreliance or improper formulation also risks promoting resistance or masking infections.
To support responsible use, educators, regulatory groups, and suppliers share a common mission. They encourage traceability, patient monitoring, and tighter integration of electronic health record systems, especially for at-risk animals or repeated steroid use. Solutions grow from solid protocols, ongoing professional training, and careful, transparent communication throughout the supply chain—from production all the way to clinical dosing.
Access to effective corticosteroids often circles back to price, import restrictions, and approval hurdles. I’ve watched practices weigh the costs of flumethasone acid against generics like prednisolone. Upfront, this molecule can look pricier, but careful dosing and less frequent need for re-treatment mean lower total cost for stubborn or chronic cases over time. For clinics in regions with tight regulatory controls, documentation from producers carries extra weight—batch records, manufacturing audits, and validated analytical data smooth path through customs and regulatory checkpoints.
Global health agencies play an active role in reviewing and certifying corticosteroids. Recent changes in veterinary and human regulations reflect the demand for transparency surrounding raw ingredient sources, purity claims, and absence of contamination. Reputable suppliers back up their products with robust analytical reporting, long-term stability studies, and customer service that answers both technical and clinical questions promptly—qualities I’ve seen clinics value year after year.
Attention to sustainability and environmental stewardship in chemical manufacturing and pharmaceutical distribution has grown over the years. Powerful corticosteroids, if handled without care, may slip into water systems or animal waste. Forward-thinking suppliers offer clear guidance about storage, safe handling, and waste disposal, minimizing environmental burden. Clear labeling encourages responsible use among experienced users, helping ensure these molecules bring benefit without introducing new risks to livestock or surrounding habitats.
In some communities, decisions about bringing new corticosteroids into regular use spark lively debate. Balancing animal health, human benefit, and ecological impact means considering both the short-term need for rapid symptom relief and the longer-term effects on local ecosystems. Sound stewardship requires not just technical knowledge—an open channel of discussion between health providers, regulatory bodies, and suppliers builds trust that supports ongoing access to advanced options like flumethasone acid.
Quality corticosteroid compounds don’t just show up at the right time—they reshape what’s possible for clinicians and researchers working at the edge of inflammation management. Flumethasone acid’s strengths lie in its selective targeting, reliable dose-response, and manageable side effect landscape. Real results happen in the day-to-day, as health professionals pivot from older, less predictable options to modern molecules that fit contemporary standards for safety and effectiveness.
Feedback loops among users, producers, and oversight groups drive improvements. Technical advances in synthesis and testing, paired with accessible education around risks and responsibilities, set the stage for more widespread—and safer—adoption. Clinics that remain plugged into evolving standards build resilience and confidence among their staff, improving patient outcomes over months and years.
Training and mentorship never run out of value. Most clinics or research programs benefit from periodic workshops focused on responsible corticosteroid use. Flumethasone acid presents unique points for discussion: precision in compounding, attention to batch documentation, and best practices for administering or transitioning therapies. Promoting open discussion around tricky cases or ambiguous guidelines lets new and seasoned practitioners learn together.
In my experience, clinics and research institutions that invest in continuing education tap into the full potential of molecules like flumethasone acid. They encourage systematic recordkeeping, open dialogue with suppliers, and an evidence-based approach to formulation and prescribing. This collaborative attitude reduces risk, builds institutional knowledge, and raises the quality of care delivered.
Pharmaceutical and veterinary science never stop evolving. Flumethasone acid’s presence in the current toolkit reflects not only its chemical advantages, but a broader trend toward targeted, responsible intervention. As analytical tools and formulation science advance, expectations on users and suppliers grow. Extracting the best from this product means staying proactive—anticipating shifts in evidence, regulatory guidance, or patterns of disease.
Community networks, professional societies, and online forums all help share lessons and feedback, catching safety signals early and highlighting successes for others to learn from. That spirit of peer review and open feedback strengthens trust and innovation. Safe, supported use of flumethasone acid will likely hinge on the strength of these communities in years to come.
Flumethasone acid marks an important shift in how health professionals approach complex inflammation and immune challenges. By moving beyond the limitations of older corticosteroids, this molecule opens doors for more refined, precise, and patient-friendly care. Success rests not just on technical quality, but on the commitment of every participant—from producers to prescribers—to learning, adaptation, and shared stewardship. As needs change and standards rise, products like flumethasone acid help raise the bar for what clinical and veterinary care can achieve.